🩺 ANTIOBESITY PREPARATIONS 🏷️ Lipase inhibitor
👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Cap 120 mg 042142 21 Rs.1,785.00 Rs.2,100.00

📋 Indications & Clinical Dosage

*Obesity with body mass index(BMI) 30 kg/m2 and greater, or BMI 28 kg/m2 and greater with other risk factors:* Adults: 120 mg before, during or up to one hr after each main meal. Continue treatment after 12 wk if 5% of initial body weight is reduced. If a meal is missed or contains no fat, the dose of orlistat should be omitted. Advise diet rich in fruit and vegetables containing approx 30% calories from fat. Consider a multivitamin supplement Children: Not recommended.

⛔ Contraindications

Chronic malabsorption, cholestasis.

⚠️ Precautions & Warnings

Chronic kidney disease may impair absorption of fat-soluble vitamins, volume depletion. Monitor antidiabetic drug treatment as diabetic patients lose weight.

🔄 Drug Interactions

Acarbose, anticoagulants, amiodarone, fat-soluble vitamins, cyclosporin.

⚠️ Adverse Reactions / Side Effects

Abdominal distension, abdominal pain, anxiety, faecal incontinence, faecal urgency, flatulence, gingival disorders, headache, hypoglycaemia, liquid stools, malaise, menstrual disturbances, oily leakage from rectum, oily stools, respiratory infections, tooth disorders, urinary tract infection, bullous eruptions, cholelithiasis, diverticulitis, hepatitis, hypothyroidism, oxalate nephropathy, rectal bleeding.

🤰 Pregnancy & Lactation Safety

Pregnancy Risk:
Caution advised.
Lactation / Breastfeeding:
Contraindicated or not recommended.

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: ORLISTAT

Rs.1,912.50 2,250.00
DYTE
DYSON R L
Rs.779.00
FABECAL
HIGHNOON
Rs.1200.00
FATNIL
FERROZA
Rs.779.00
G-ORLI
GT PHARMA
Rs.390.00
OBESTAT
PANACEA
Rs.510.00

More from MARTIN DOW

ALVOSUNI
MARTIN DOW
Rs.46,800.00
ANEXATE
MARTIN DOW
View →
APRANAX
MARTIN DOW
Rs.274.75

Same category: ANTIOBESITY PREPARATIONS

ORLIDAN
DANAS
Rs.520.00
Rs.1500.00
ORLINIG
HONIG PHARMA
Rs.448.50

⚡ Quick Actions

💬 Share via WhatsApp